Simple Summary Glioblastoma multiforme is an aggressive grade IV lethal brain tumour with
a median survival of 14 months. Despite surgery to remove the tumour, and subsequent …

Cancer is a leading cause of death worldwide, with approximately 19 million new cases
each year. Lately, several novel chemotherapeutic drugs have been introduced, efficiently …

It was recently demonstrated the penfluridol inhibited breast tumor growth and metastasis
and this was associated with downregulation of α6-and β4-integrins. In this study, we …

Glioblastoma (GBM) is the most common brain tumor with poor survival rate. Our results
show that penfluridol, an antipsychotic drug significantly reduced the survival of ten adult …

Simple Summary Despite significant advancements in neuroblastoma therapy, over half of
the children with high-risk neuroblastoma will suffer disease relapse. Protein phosphatase …

MicroRNAs (miRNAs or miRs) contribute to the development of various malignant
neoplasms, including glioblastoma multiforme (GBM). The present study aimed to explore …

Background Chemotherapy is the main treatment for acute myeloid leukemia (AML), but the
cure rates for AML patients remain low, and the notorious adverse effects of …

Background Pancreatic ductal adenocarcinoma (PDAC) has a low survival, its incidence is
rising and little therapeutic improvements are expected in the near future. It has been …

The bacterium Enterococcus faecalis has increasingly attracted global attention as an
important opportunistic pathogen due to its ability to form biofilms that are known to increase …

Background Hepatocellular carcinoma (HCC) is a multifactor-driven malignant tumor with
rapid progression, which causes the difficulty to substantially improve the prognosis of HCC …